IP Library Granted Patent US 11,786,839
Granted Patent B2
US 11,786,839 · App. 17/055,822 · Granted Oct 17, 2023

Eutectic extract formation and purification

Inventors: Michaël Laguerre (Le Pontet, FR); Robert Harris (Leicester, GB); Alexis Lavaud (Sierentz, FR); Mathieu Tenon (Malemort du Comtat, FR); Simona Birtic (Cavaillon, FR); Antoine Charles Bily (Vedène, FR); Andrew Peter Abbott (Leicester, GB)
B01D11/0288A61K8/416A61K8/4926A61K8/4946A61K8/97A61K36/23A61K36/28A61K36/45A61K36/53A61K36/725A61K36/752A61K36/81A61Q19/00A61K2236/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,786,839
App. No.
17/055,822
Granted
Oct 17, 2023
Kind
B2
Abstract

The present invention relates to processes for forming eutectic extracts, processes for purifying eutectic extracts and uses of the eutectic extracts such as in food-stuffs, pharmaceuticals, nutraceuticals and supplements, such as food supplements and sports supplements.

Claims (13)

1. A process for the purification of a eutectic extract or eutectic combination comprising:

(i) mixing a eutectic extract or eutectic combination with a liquid that is immiscible in the eutectic extract or eutectic combination to form a mixture;

(ii) allowing the mixture formed in step (i) to equilibrate into two phases; and

(iii) separating the eutectic phase from the phase comprising the liquid that is immiscible in the eutectic extract or eutectic combination,

wherein the liquid that is immiscible in the eutectic extract or eutectic combination is a lipid phase in a liquid form, a terpenic solvent, or an alcohol.

2. The purification process according to claim 1 , wherein steps (i) to (iii) are repeated using the separated eutectic phase as the eutectic extract or eutectic combination in step (i) of the purification process.

3. The purification process according to claim 1 , wherein the eutectic extract or eutectic combination may be prepared by

(a) forming a mixture between at least one exogenous amine and biological material which is at least one of plant material, animal material, or prokaryotic biological material,

(b) allowing the mixture to interact to form a liquid, gel or gel-like eutectic extract, and optionally, separating the liquid or gel/gel-like mixture from undissolved solids, or may be a eutectic extract or eutectic combination that has been previously prepared by extracting a biological material using a pre-prepared eutectic solvent.

4. The purification process according to claim 1 , wherein the lipid phase in a liquid form is selected from free fatty acids, free fatty alcohol, triacylglycerols, and/or vegetable oil.

5. The purification process according to claim 1 , wherein the terpene solvent is limonene or para-menthane.

6. The purification process according to claim 1 , wherein the weight ratio of eutectic extract to immiscible liquid is from about 1:0.1 to about 1:10.

7. The purification process according to claim 1 , wherein step (iii) separates the eutectic phase from the phase comprising the liquid that is immiscible in the eutectic extract by removing exogenous amine that has not formed a complex with the endogenous compounds in the biological material.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2024
From: LAGUERRE, MICHAËL; LAVAUD, ALEXIS; TENON, MATHIEU; BIRTIC, SIMONA; BILY, ANTOINE CHARLES
To: GIVAUDAN FRANCE NATURALS SAS
Reel/Frame 066448/0122 →
Priority Claims (1)
GB 1807968 · May 16, 2018 · national
Continuity (1)
Related Publication 20210299592A1 · Sep 30, 2021